BetterLife Pharma Inc. Files July 2025 6-K Report
Ticker: BETRF · Form: 6-K · Filed: Jul 28, 2025 · CIK: 1464165
Sentiment: neutral
Topics: reporting, foreign-issuer, corporate-history
Related Tickers: BETRF
TL;DR
BetterLife Pharma (BETRF) filed its July 6-K, standard reporting update.
AI Summary
BetterLife Pharma Inc. filed a Form 6-K on July 28, 2025, reporting for the month of July 2025. The company, formerly known as Pivot Pharmaceuticals Inc. and Neurokine Pharmaceuticals Inc., is incorporated in A1 and has its principal executive offices in Vancouver, BC, Canada. This filing is made under the 1934 Securities Exchange Act.
Why It Matters
This filing provides routine updates for investors regarding BetterLife Pharma Inc.'s reporting status and corporate history, including previous name changes.
Risk Assessment
Risk Level: low — This is a routine 6-K filing, which typically contains information that is not market-moving or indicative of significant new risks.
Key Players & Entities
- BetterLife Pharma Inc. (company) — Filer
- Pivot Pharmaceuticals Inc. (company) — Former Company Name
- Neurokine Pharmaceuticals Inc. (company) — Former Company Name
- 20250728 (date) — Filing Date
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934, used to provide information that the company makes or is required to make public in its home country, files with a stock exchange, or distributes to its security holders.
When was BetterLife Pharma Inc. previously known by other names?
BetterLife Pharma Inc. was formerly known as Pivot Pharmaceuticals Inc. (name change date: 20150417) and Neurokine Pharmaceuticals Inc. (name change date: 20090514).
Where is BetterLife Pharma Inc. located?
The company's principal executive office is located at 1275 West 6th Avenue, #300, Vancouver, BC, Canada V6H 1A6.
What is the SIC code for BetterLife Pharma Inc.?
The Standard Industrial Classification (SIC) code for BetterLife Pharma Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Does BetterLife Pharma Inc. file annual reports under Form 20-F or 40-F?
BetterLife Pharma Inc. indicates it files annual reports under cover of Form 20-F.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on July 28, 2025 regarding BetterLife Pharma Inc. (BETRF).